The role of pharmacogenetically-variable cytochrome P450 enzymes in

Author： Howard Lisa A   Sellers Edward M   Tyndale Rachel F  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.3, Iss.2, 2002-03, pp. : 185-199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Role of Retinoids, Rexinoids and Thyroid Hormone in the Expression of Cytochrome P450 Enzymes

By  

Current Drug Metabolism, Vol. 12, Iss. 2, 2011-02 ,pp. : 71-88

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Aryl Hydrocarbon Receptor-Regulated Cytochrome P450 Enzymes in Glioma

By  

Current Pharmaceutical Design, Vol. 19, Iss. 40, 2013-12 ,pp. : 7155-7166

Bentham Science Publishers

Access to resources Recommend Favorite

Role of NF-&kgr;B in the Regulation of Cytochrome P450 Enzymes

By  

Current Drug Metabolism, Vol. 10, Iss. 2, 2009-02 ,pp. : 164-178

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer treatment and pharmacogenetics of cytochrome P450 enzymes

By Schaik Ron  

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 513-522

Springer Publishing Company

Access to resources Recommend Favorite

Cytochrome p450 enzymes and cardiovascular disease

By Hunter Arwen L   Cruz Rani P   Cheyne Bo M   McManus Bruce M   Granville David J  

Canadian Journal of Physiology and Pharmacology, Vol. 82, Iss. 12, 2004-12 ,pp. : 1053-1060

NRC Research Press

Access to resources Recommend Favorite